BCL2 and B-cell chronic lymphocytic leukemia: Venetoclax is a BCL-2 inhibitor used in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and AML patients who are not eligible for standard chemotherapy.